Sphere 3D Corp
Change company Symbol lookup
Select an option...
ANY Sphere 3D Corp
HMY Harmony Gold Mining Company Ltd
PLX Protalix Biotherapeutics Inc
BEDU Bright Scholar Education Holdings Ltd
USAS Americas Gold and Silver Corporation
AA Alcoa Corp
CRIS Curis Inc
APTO Aptose Biosciences Inc
RGLS Regulus Therapeutics Inc
IMH Impac Mortgage Holdings Inc
Go

Information Technology : Software | Small Cap Value
Based in Canada
Company profile

Sphere 3D Corp is a Canada-based company engaged in software development sector. The Company delivers data management, desktop and application virtualization solutions through hybrid cloud, cloud and on premise implementations by its global reseller network. The Company achieves this through a combination of containerized applications, virtual desktops, virtual storage and physical hyper-converged platforms. The Company’s products allow organizations to deploy a combination of public, private or hybrid cloud strategies while backing them up with the latest storage solutions. The Company has a portfolio of brands including RDX, Glassware 2.0, SnapCLOUD, SnapServer, SnapSync, NEO and V3 .

Closing Price
$2.68
Day's Change
-0.53 (-16.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.18
Day's Low
2.40
Volume
(Below Average)
Volume:
19,187,377

10-day average volume:
23,615,748
19,187,377

CLASS ACTION UPDATE for BLU, NEPT and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

11:30 am ET May 4, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

BLU Shareholders Click Here: https://www.zlk.com/pslra-1/bellus-health-inc-loss-submission-form?prid=15452&wire=1

NEPT Shareholders Click Here: https://www.zlk.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?prid=15452&wire=1

ACAD Shareholders Click Here: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15452&wire=1

* ADDITIONAL INFORMATION BELOW *

Image: https://www.accesswire.com/users/newswire/images/644377/ZLK_PR_Logo-3.png

BELLUS Health Inc. (NASDAQ:BLU)

BLU Lawsuit on behalf of: investors who purchased September 5, 2019 - July 5, 2020

Lead Plaintiff Deadline : May 17, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/bellus-health-inc-loss-submission-form?prid=15452&wire=1

According to the filed complaint, during the class period, BELLUS Health Inc. made materially false and/or misleading statements and/or failed to disclose that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)

NEPT Lawsuit on behalf of: investors who purchased July 24, 2019 - February 16, 2021

Lead Plaintiff Deadline : May 17, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?prid=15452&wire=1

According to the filed complaint, during the class period, Neptune Wellness Solutions Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

ACAD Lawsuit on behalf of: investors who purchased June 15, 2020 - April 4, 2021

Lead Plaintiff Deadline : June 18, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15452&wire=1

According to the filed complaint, during the class period, Acadia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com:

https://www.accesswire.com/644377/CLASS-ACTION-UPDATE-for-BLU-NEPT-and-ACAD-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.